FR2255079B1 - - Google Patents

Info

Publication number
FR2255079B1
FR2255079B1 FR7442586A FR7442586A FR2255079B1 FR 2255079 B1 FR2255079 B1 FR 2255079B1 FR 7442586 A FR7442586 A FR 7442586A FR 7442586 A FR7442586 A FR 7442586A FR 2255079 B1 FR2255079 B1 FR 2255079B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7442586A
Other versions
FR2255079A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2365102A external-priority patent/DE2365102C2/de
Priority claimed from DE19742441284 external-priority patent/DE2441284C2/de
Priority claimed from DE19742444618 external-priority patent/DE2444618C2/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2255079A1 publication Critical patent/FR2255079A1/fr
Application granted granted Critical
Publication of FR2255079B1 publication Critical patent/FR2255079B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7442586A 1973-12-21 1974-12-23 Expired FR2255079B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2365102A DE2365102C2 (de) 1973-12-21 1973-12-21 Neue Pregnansäure-Derivate
DE19742441284 DE2441284C2 (de) 1973-12-21 1974-08-27 Verfahren zur Herstellung von Pregnansäure-Derivaten
DE19742444618 DE2444618C2 (de) 1974-09-16 1974-09-16 Neue Pregnan-21-säure-Derivate

Publications (2)

Publication Number Publication Date
FR2255079A1 FR2255079A1 (fr) 1975-07-18
FR2255079B1 true FR2255079B1 (fr) 1978-02-03

Family

ID=27185702

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7442586A Expired FR2255079B1 (fr) 1973-12-21 1974-12-23

Country Status (22)

Country Link
US (1) US3944577A (fr)
JP (1) JPS5840559B2 (fr)
AT (2) AT347612B (fr)
AU (1) AU496759B2 (fr)
BE (1) BE823682A (fr)
CA (1) CA1060885A (fr)
CH (1) CH612688A5 (fr)
DD (1) DD119586A5 (fr)
DK (1) DK139361C (fr)
EG (1) EG11731A (fr)
ES (1) ES433216A1 (fr)
FI (1) FI53708C (fr)
FR (1) FR2255079B1 (fr)
GB (1) GB1497265A (fr)
IE (1) IE40456B1 (fr)
IL (1) IL46296A (fr)
IT (1) IT1043908B (fr)
NL (1) NL7416805A (fr)
NO (1) NO744623L (fr)
PH (1) PH11030A (fr)
SE (1) SE410607B (fr)
YU (1) YU338574A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants
DK118776A (da) * 1975-03-21 1976-09-22 Schering Ag Pregnansyrederivater
US4181720A (en) * 1978-04-05 1980-01-01 Syntex (U.S.A.) Inc. Corticosteroid antiinflammatory agents
US4257969A (en) * 1980-01-23 1981-03-24 E. R. Squibb & Sons, Inc. 16,17-Dihydroxypregnene-21-carboxylic acids and derivatives
US4588530A (en) * 1982-07-30 1986-05-13 Florida Agricultural And Mechanical University Anti-inflammatory prednisolone steroids
US4511511A (en) * 1982-12-15 1985-04-16 Crozer-Chester Medical Center Prednisolone derivatives
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
JP3176075B2 (ja) * 1991-03-04 2001-06-11 帝國製薬株式会社 新規なステロイド誘導体
WO2003030823A2 (fr) * 2001-10-05 2003-04-17 Combinatorx, Incorporated Combinaisons permettant le traitement des troubles inflammatoires
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
MX2008014828A (es) * 2006-05-22 2009-02-06 Combinatorx Inc Metodos y composiciones para el tratamiento de enfermedades o condiciones asociadas con niveles incrementados de proteina c-reactiva, interleucina-6 o interferon-gamma.
US20090075955A1 (en) * 2007-09-19 2009-03-19 Combinatorx, Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
MX2010006724A (es) * 2007-12-17 2010-09-07 Combinatorx Inc Regimenes terapeuticos para el tratamiento de desordenes inmunoinflamatorios.
JP7330718B2 (ja) 2019-02-28 2023-08-22 三菱重工業株式会社 ガスタービンプラント、及びその排出二酸化炭素回収方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833563A (en) * 1971-10-04 1974-09-03 Schering Ag Novel pregnanoic acid derivatives
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
DE2260303C2 (de) * 1972-12-06 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von Pregnansäurederivaten

Also Published As

Publication number Publication date
DK139361C (da) 1979-07-09
IL46296A0 (en) 1975-03-13
GB1497265A (en) 1978-01-05
DK139361B (da) 1979-02-05
IE40456B1 (en) 1979-06-06
ATA398978A (de) 1979-08-15
PH11030A (en) 1977-10-25
CA1060885A (fr) 1979-08-21
NO744623L (fr) 1975-07-21
YU338574A (en) 1982-05-31
BE823682A (fr) 1975-06-20
JPS5840559B2 (ja) 1983-09-06
ATA1021774A (de) 1978-05-15
EG11731A (en) 1977-11-30
AT347612B (de) 1979-01-10
SE7416038L (fr) 1975-06-23
FI53708C (fi) 1978-07-10
AU7658574A (en) 1976-06-24
SE410607B (sv) 1979-10-22
US3944577A (en) 1976-03-16
IL46296A (en) 1978-10-31
CH612688A5 (fr) 1979-08-15
DK667574A (fr) 1975-09-08
FR2255079A1 (fr) 1975-07-18
FI53708B (fr) 1978-03-31
DD119586A5 (fr) 1976-05-05
AT355744B (de) 1980-03-25
AU496759B2 (en) 1978-10-26
NL7416805A (nl) 1975-06-24
IE40456L (en) 1975-06-21
JPS5095257A (fr) 1975-07-29
FI370774A (fr) 1975-06-22
IT1043908B (it) 1980-02-29
ES433216A1 (es) 1977-03-01

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
AU476696B2 (fr)
AU477823B2 (fr)
AR195948A1 (fr)
AR195311A1 (fr)
AR197627A1 (fr)
AU477824B2 (fr)
AR196382A1 (fr)
AU476873B1 (fr)
AR196212Q (fr)
AR196123Q (fr)
BG18902A1 (fr)
AU479496A (fr)
BG20036A1 (fr)
BG19961A1 (fr)
BG19951A1 (fr)
BG19541A1 (fr)
BG19401A1 (fr)
BG19285A1 (fr)
CH307274A4 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse